retatrutide maximum dose clinical trials Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide Dosing Guide for Researchers

DOSING USED IN PHASE 3 STUDIES In the most recent studies from the TRIUMPH programme (Phase 3) , retatrutide was administered as follows: Route: Subcutaneous Frequency: Once weekly Study duration: Approximately 68 weeks Phase 3 Schedule Recommended Dosage (Clinical Research Escalation Model) Retatrutide is administered once weekly using a gradual dose escalation to improve tolerability

Nearly half of the participants on that dose lost at least 30% of their body weight

Avraham SA, Hossein J, Somri F, Hawash N, Hochman O

For daily injectable GLP-1 medications : Liraglutide (Victoza/Saxenda) : If you miss a daily dose, resume your regular dosing schedule with the next scheduled dose

(In 2024, Hims & Hers brought in $1.5 billion in revenue, a 69 percent increase from the previous year.) Practitioners can prescribe the medications to patients remotely, and then the telehealth company ships them to their homes

Sometimes people call this Ozempic face or GLP-1 face because its so common